On 14th May, Konica Minolta announced its financial results for Q1 2021. Due to the companies reporting cycle, this is its fourth fiscal quarter. During the quarter, sales originating from the healthcare business reached ¥35.4bn, compared with ¥33.0bn in Q1 2020, an increase of approximately +7.3% year-on-year. On the trailing 12-month basis, sales remain lower due to the sales decline in Q2 and Q3 2020.
The healthcare business is segmented into ‘healthcare’ and ‘precision medicine’. Quarterly sales growth was driven by higher sales from the healthcare segment, partially offset by the precision medicine segment. Quarterly sales revenue from the healthcare segment saw a recovering trend against a backdrop of strong demand in the Japanese hospital market. Sales volume of diagnostic ultrasound systems continued to increase in Japan in the area of orthopaedics, dialysis, and obstetrics. Quarterly sales declined from the precision medicine segment, driven by the US market, due to a drop in the number of patients coming into hospitals as well as clinical trial volunteers. From a geographical perspective, during the quarter, sales revenue continued to increase in China, Japan, and other Asian countries. This was accompanied by the continued strengthening of revenue from Europe and the United States which “came back to more than 90% [pre-COVID levels] year-on-year.”